| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 13, 2009On World Diabetes Day, Medtronic Highlights the Growing Clinical Evidence for the Benefits of Continuous Glucose Monitoring in Diabetes Control
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 13, 2009-- In acknowledgement of this year’s World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take...
-
Aug 22, 2006
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....
-
May 23, 2006
MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...
-
Nov 16, 2005
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 16, 2005--Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues Grew 34%; Worldwide Market Share Continued to Increase -- Spinal...
-
May 24, 2005
Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues of $682 million in the Quarter Increases Medtronic Worldwide ICD Market Share to 50 Percent -- Spinal Business...
-
Aug 18, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 2004-- Broad Based Growth Was Led By 31 Percent Increase In Quarterly Implantable Defibrillator Revenues Medtronic, Inc. (NYSE:MDT) today announced quarterly...
-
May 4, 2004
MINNEAPOLIS--(BUSINESS WIRE)--May 24, 2004--Medtronic, Inc. (NYSE:MDT) today announced record quarterly revenues of $2.665 billion, an increase of 24.1 percent over the $2.148 billion of the...
-
Feb 10, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...
-
Nov 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 12, 2003-- Record Quarter Led by Continued Strong Growth in Implantable Defibrillator and Spinal Revenues, Together With Accelerated Growth in Diabetes; All...
-
Aug 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 12, 2003-- Continued Strong Performances in Cardiac Rhythm Management, Spinal and Neurological Spur Growth Continuing to benefit from widespread acceptance of...